Bank Of New York Mellon Corp Spectrum Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.32 - $0.52 $28,345 - $46,061	88,579 New	88,579 $32,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $391 - $1,421	911 Added 1.04%	88,662 $38,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $285,879 - $571,758	-408,399 Reduced 82.31%	87,751 $69,000
Q1 2022 May 11, 2022	SELL	$0.63 - $1.59 $536,446 - $1.35 Million	-851,503 Reduced 63.18%	496,150 $640,000
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $33,064 - $63,004	-26,035 Reduced 1.9%	1,347,653 $1.71 Million
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.82 $130,438 - $231,755	60,669 Added 4.62%	1,373,688 $2.99 Million
Q2 2021 Aug 11, 2021	SELL	$2.89 - $4.45 $407,117 - $626,875	-140,871 Reduced 9.69%	1,313,019 $4.92 Million
Q1 2021 May 13, 2021	SELL	$2.9 - $4.09 $178,199 - $251,322	-61,448 Reduced 4.06%	1,453,890 $4.74 Million
Q4 2020 Feb 09, 2021	BUY	$3.38 - $5.14 $49,523 - $75,311	14,652 Added 0.98%	1,515,338 $5.17 Million
Q3 2020 Nov 12, 2020	BUY	$2.99 - $4.9 $738,042 - $1.21 Million	246,837 Added 19.69%	1,500,686 $6.12 Million
Q2 2020 Aug 12, 2020	BUY	$2.11 - $3.38 $137,331 - $219,990	65,086 Added 5.48%	1,253,849 $4.24 Million
Q1 2020 May 06, 2020	SELL	$1.83 - $3.45 $134,056 - $252,729	-73,255 Reduced 5.8%	1,188,763 $2.77 Million
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $159,904 - $472,860	45,687 Added 3.76%	1,262,018 $4.59 Million
Q3 2019 Nov 07, 2019	BUY	$7.03 - $9.7 $37,568 - $51,836	5,344 Added 0.44%	1,216,331 $10.1 Million
Q2 2019 Aug 12, 2019	BUY	$7.36 - $11.26 $159,910 - $244,646	21,727 Added 1.83%	1,210,987 $10.4 Million
Q1 2019 May 14, 2019	BUY	$9.08 - $11.84 $314,158 - $409,652	34,599 Added 3.0%	1,189,260 $12.7 Million
Q4 2018 Feb 11, 2019	SELL	$6.39 - $16.99 $9,099 - $24,193	-1,424 Reduced 0.12%	1,154,661 $10.1 Million
Q3 2018 Nov 09, 2018	BUY	$16.52 - $24.82 $828,593 - $1.24 Million	50,157 Added 4.54%	1,156,085 $0
Q2 2018 Aug 06, 2018	BUY	$14.31 - $21.75 $487,541 - $741,022	34,070 Added 3.18%	1,105,928 $23.2 Million
Q1 2018 May 15, 2018	BUY	$16.09 - $23.07 $369,555 - $529,871	22,968 Added 2.19%	1,071,858 $17.2 Million
Q4 2017 Feb 09, 2018	BUY	$13.36 - $20.73 $14 Million - $21.7 Million	1,048,890	1,048,890 $19.9 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account